---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-127964"
form_type: "8-K"
ticker: "TERN"
cik: "0001831363"
company_name: "Terns Pharmaceuticals, Inc."
filed_at: "2024-11-18T23:59:59+00:00"
generated_at: "2026-05-29T23:11:19.988971+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Terns Pharmaceuticals appoints Heather Turner to board; Ann Taylor resigns

## Summary
- Heather Turner, former CEO of Carmot Therapeutics, appointed to Board of Directors effective Nov 18.
- Ann Taylor resigned effective Nov 18; departure not due to any disagreement with company operations.
- Turner brings 25 years biotech experience; led Carmot's $3.1B acquisition by Roche.
- Turner also appointed to Audit Committee; eligible for standard non-employee director compensation.

## SEC filing metadata
- accession: 0000950170-24-127964
- form_type: 8-K
- ticker: TERN
- cik: 0001831363
- company_name: Terns Pharmaceuticals, Inc.
- filed_at: 2024-11-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831363/000095017024127964/0000950170-24-127964-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831363/000095017024127964/tern-20241114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-127964
- JSON: https://secwatch.observer/filing/0000950170-24-127964.json
- Plain text: https://secwatch.observer/filing/0000950170-24-127964.txt

## Source-grounded claims
- claim_id: 130fa7f27d
  claim: Heather Turner was appointed as Member of the Board of Directors at Terns Pharmaceuticals, Inc..
  evidence_excerpt: On November 15, 2024, the Board appointed and elected Heather Turner as a member of the Board, effective as of November 18, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831363/000095017024127964/0000950170-24-127964-index.htm
- claim_id: 3db0bb6d06
  claim: Ann Taylor resigned as Member of the Board of Directors at Terns Pharmaceuticals, Inc..
  evidence_excerpt: On November 14, 2024, Ann Taylor notified Terns Pharmaceuticals, Inc. (the “Company”) of her resignation from the Company’s Board of Directors (the “Board”), effective as of November 18, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831363/000095017024127964/0000950170-24-127964-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.